More about

Remission

News
May 22, 2024
3 min read
Save

Documentation of asthma remission endpoints varies

Documentation of asthma remission endpoints varies

SAN DIEGO — Few patients are evaluated based on all seven endpoints of guidelines indicating complete asthma remission, according to a poster presented at the American Thoracic Society International Meeting.

News
May 10, 2024
2 min read
Save

Tocilizumab taper 'reasonable' in giant cell arteritis remission despite flare risk

Tocilizumab taper 'reasonable' in giant cell arteritis remission despite flare risk

DESTIN, Fla. — Rheumatologists should consider tapering tocilizumab for patients with giant cell arteritis in remission despite the increased risk for flare, said a speaker at the Congress of Clinical Rheumatology East annual meeting.

News
April 24, 2024
2 min read
Save

Tapering csDMARDs in RA remission fails to achieve non-inferiority vs. stable dose

Tapering csDMARDs in RA remission fails to achieve non-inferiority vs. stable dose

Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority vs. stable dosage, according to data.

News
March 08, 2024
2 min read
Save

Four children achieve treatment-free HIV remission for 1 year

DENVER — Four children born with HIV who initiated ART within 48 hours of delivery later remained in treatment-free remission for over a year after ART was paused, researchers reported.

News
February 29, 2024
1 min read
Save

Positive results announced in phase 2a trial of take-home microdosing drug for depression

Positive results announced in phase 2a trial of take-home microdosing drug for depression

MindBio Therapeutics has announced positive topline results from its take-home phase 2a clinical trial of MB22001 in patients with depression, according to a company press release.

News
February 15, 2024
2 min read
Save

SLE-DAS remission, low disease activity show promise as treat-to-target measures

SLE-DAS remission, low disease activity show promise as treat-to-target measures

Remission and low disease activity can discriminate between patients taking active drug vs. placebo in clinical trials and are linked to health-related quality of life, according to data in Arthritis Care & Research.

News
December 11, 2023
3 min read
Save

Biomarkers might predict asthma remission after anti-IL-5 therapy

Biomarkers might predict asthma remission after anti-IL-5 therapy

Sputum neutrophil percentage and levels of eotaxin-1, IL-5 and eosinophil peroxidase may be used to predict remission among patients with severe asthma 1 year after anti-IL-5 therapy, according to a study published in CHEST.

News
October 04, 2023
2 min read
Save

Revumenib trial meets complete remission endpoint for acute leukemia subsets

Revumenib trial meets complete remission endpoint for acute leukemia subsets

Revumenib conferred complete remission or complete remission with partial hematologic recovery in nearly one-quarter of patients with two acute leukemia subtypes, according to the agent’s manufacturer.

News
September 13, 2023
3 min read
Save

Workgroup releases consensus definition for clinical remission in asthma on treatment

Workgroup releases consensus definition for clinical remission in asthma on treatment

A multi-organizational panel has developed a working definition for clinical remission in asthma, according to a paper published in Annals of Allergy, Asthma & Immunology.

News
September 12, 2023
2 min read
Save

Clinical remission of severe asthma ‘achievable goal’ with mepolizumab

Clinical remission of severe asthma ‘achievable goal’ with mepolizumab

Patients with severe asthma achieved clinical remission based on a four-component definition with 52 weeks of mepolizumab, according to an abstract presented at the European Respiratory Society International Congress.

View more